Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Journal of Pain Research|April 29, 2025
Device Evaluation, Treatment, and Explantation Recommendations (DETER): Review and Best Practices for Managing Neuromodulation Device InfectionsScott G Pritzlaff, Johnathan Heck Goree, Ryan Keith Dare, et al.
Pain Practice : the Official Journal of World Institute of Pain|March 30, 2024
The current state of training in pain medicine fellowships: An Association of Pain Program Directors (APPD) survey of program directorsSayed Emal Wahezi, Trent D Emerick, Moorice Caparó, et al.
Neuromodulation : Journal of the International Neuromodulation Society|September 10, 2024
Maximal Analgesic Effect Attained by the Use of Objective Neurophysiological Measurements With Closed-Loop Spinal Cord StimulationRobert M Levy, Nagy A Mekhail, Leonardo Kapural, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 11, 2022
High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled TrialErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
Journal of Pain Research|March 19, 2025
An Evidence-Based Consensus for the Use of Neurostimulation for the Treatment of Non-Surgical Low Back Pain: The NEURON GroupTimothy Ray Deer, Jason E Pope, Erika A Petersen, et al.
Diabetes Research and Clinical Practice|August 3, 2023
Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trialErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
JAMA Neurology|April 5, 2021
Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical TrialErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
Regional Anesthesia and Pain Medicine|December 2, 2025
Clinical utility of ECAP dosing in a real-world population delivered via EVOKE therapy: the ECAP studyJason E Pope, Gregory L Smith, Johnathan A Goree, et al.
Pageof 13